What You Should Know:
– NovaSignal Corp., a Los Angeles-based medical technology and data company specializing in the assessment and management of brain health, announced today it has closed $37M in a Series C1 round of funding led by Alpha Edison and Reimagined Ventures.
– By applying robotics and artificial intelligence to cerebral ultrasound, NovaSignal uniquely captures blood flow data in real time. The NovaSignal Platform empowers the clinical team with critical, real-time information about cerebral blood flow to guide diagnosis and improve patient outcomes.
– The company will use the capital to support NovaSignal’s continued commercial expansion, consistent delivery of product innovation, and new clinical trials to increase indications within and beyond stroke.